一家系2例先天性红细胞生成性卟啉病并文献复习

杨月芊, 韩洋, 张慈柳, 谢岷

中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (10) : 1271-1275.

PDF(734 KB)
HTML
PDF(734 KB)
HTML
中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (10) : 1271-1275. DOI: 10.7499/j.issn.1008-8830.2503048
罕见病研究

一家系2例先天性红细胞生成性卟啉病并文献复习

作者信息 +

Two siblings with congenital erythropoietic porphyria in one family: case report and literature review

Author information +
文章历史 +

摘要

例1,女,7岁;例2,男(例1胞弟),3岁。2例患儿均在出生后出现粉红色尿,光照部位(颜面部、双手)出现皮肤水疱,继而破溃、结痂、瘢痕形成,关节挛缩导致活动障碍等临床表现。2例患儿基因检测均为UROS基因c.776T>C(p.Leu259Pro)纯合变异,确诊为UROS基因变异常染色体隐性遗传性先天性红细胞生成性卟啉病。该病例报道提示,对于不明原因婴幼儿期溶血性贫血、粉红色尿、严重光敏性皮炎者,应考虑先天性红细胞生成性卟啉病可能,尽早完善基因检测,提早干预治疗改善预后。

Abstract

Case 1 was a 7-year-old girl; Case 2 was her 3-year-old younger brother. Both children developed pink urine shortly after birth and exhibited blistering on photo-exposed areas (face and hands), followed by ulceration, crusting, scarring, and joint contractures leading to impaired mobility. Genetic testing in both patients identified a homozygous variant in the UROS gene, c.776T>C (p.Leu259Pro), confirming autosomal recessive congenital erythropoietic porphyria due to UROS mutations. This case report highlights that congenital erythropoietic porphyria should be considered in infants and young children with unexplained hemolytic anemia, pink urine, and severe photosensitive dermatitis. Early genetic testing is recommended to facilitate timely intervention and improve outcomes.

关键词

先天性红细胞生成性卟啉病 / 皮肤 / 光敏性损害 / 儿童

Key words

Congenital erythropoietic porphyria / Skin / Photosensitivity / Child

引用本文

导出引用
杨月芊, 韩洋, 张慈柳, . 一家系2例先天性红细胞生成性卟啉病并文献复习[J]. 中国当代儿科杂志. 2025, 27(10): 1271-1275 https://doi.org/10.7499/j.issn.1008-8830.2503048
Yue-Qian YANG, Yang HAN, Ci-Liu ZHANG, et al. Two siblings with congenital erythropoietic porphyria in one family: case report and literature review[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(10): 1271-1275 https://doi.org/10.7499/j.issn.1008-8830.2503048

参考文献

[1]
Madan P, Schaaf CP, Vardhan P, et al. Hans Gunther and his disease[J]. Photodermatol Photoimmunol Photomed, 2007, 23(6): 261-263. DOI: 10.1111/j.1600-0781.2007.00323.x .
[2]
Kahila A, Zamlout A, Mazloum A, et al. Congenital erythropoietic porphyria (Gunther disease): a case report[J]. Oxf Med Case Reports, 2020, 2020(7): omaa051. PMCID: PMC7376977. DOI: 10.1093/omcr/omaa051 .
[3]
Di Pierro E, Brancaleoni V, Granata F. Advances in understanding the pathogenesis of congenital erythropoietic porphyria[J]. Br J Haematol, 2016, 173(3): 365-379. DOI: 10.1111/bjh.13978 .
[4]
Horner ME, Alikhan A, Tintle S, et al. Cutaneous porphyrias part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology[J]. Int J Dermatol, 2013, 52(12): 1464-1480. DOI: 10.1111/ijd.12305 .
[5]
Venkatesh P, Garg SP, Kumaran E, et al. Congenital porphyria with necrotizing scleritis in a 9-year-old child[J]. Clin Exp Ophthalmol, 2000, 28(4): 314-318. DOI: 10.1046/j.1442-9071.2000.00330.x .
[6]
Bhusal M, Bhattarai S, Shah M, et al. Congenital erythropoietic porphyria: a case series of a rare uroporphyrinogen III synthase gene mutation in Nepalese patients[J]. JAAD Case Rep, 2021, 10: 102-106. PMCID: PMC8022107. DOI: 10.1016/j.jdcr.2021.02.017 .
[7]
Blouin JM, Ged C, Bernardo-Seisdedos G, et al. Identification of novel UROS mutations in a patient with congenital erythropoietic porphyria and efficient treatment by phlebotomy[J]. Mol Genet Metab Rep, 2021, 27: 100722. PMCID: PMC7890299. DOI: 10.1016/j.ymgmr.2021.100722 .
[8]
Gucev Z, Slavevska N, Tasic V, et al. Congenital erythropoietic porphyria with two mutations of the uroporphyrinogen III synthase gene (Cys73Arg, Thr228Met)[J]. Indian J Hum Genet, 2011, 17(2): 104-107. PMCID: PMC3214312. DOI: 10.4103/0971-6866.86199 .
[9]
Berry AA, Desnick RJ, Astrin KH, et al. Two brothers with mild congenital erythropoietic porphyria due to a novel genotype[J]. Arch Dermatol, 2005, 141(12): 1575-1579. DOI: 10.1001/archderm.141.12.1575 .
[10]
郭萍, 吴明倩, 李春鲜, 等. 先天性红细胞生成性卟啉病1例[J]. 皮肤病与性病, 2021, 43(1): 122-124. DOI: 10.3969/j.issn.1002-1310.2021.01.066 .
[11]
Suzuki H, Namiki T, Enzan N, et al. Novel mutation in the UROS gene causing congenital erythropoietic porphyria in an elderly Japanese female[J]. J Dermatol, 2022, 49(6): e215-e216. DOI: 10.1111/1346-8138.16340 .
[12]
Guo S, Wang L, Li X, et al. Identification of a novel UROS mutation in a Chinese patient affected by congenital erythropoietic porphyria[J]. Blood Cells Mol Dis, 2014, 52(1): 57-58. DOI: 10.1016/j.bcmd.2013.07.012 .
[13]
Phillips JD, Steensma DP, Pulsipher MA, et al. Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria[J]. Blood, 2007, 109(6): 2618-2621. PMCID: PMC1852202. DOI: 10.1182/blood-2006-06-022848 .
[14]
Desjardins MP, Naccache L, Hébert A, et al. Very early diagnosis and management of congenital erythropoietic porphyria[J]. Clin Pediatr (Phila), 2023, 62(5): 399-403. PMCID: PMC10170564. DOI: 10.1177/00099228221128661 .
[15]
Sudrié-Arnaud B, Legendre M, Snanoudj S, et al. An atypical case of congenital erythropoietic porphyria[J]. Genes (Basel), 2021, 12(11): 1828. PMCID: PMC8620571. DOI: 10.3390/genes12111828 .
[16]
Goudet C, Ged C, Petit A, et al. Severe perinatal presentations of Günther's disease: series of 20 cases and perspectives[J]. Life (Basel), 2024, 14(1): 130. PMCID: PMC10817338. DOI: 10.3390/life14010130 .
[17]
Salomone B C, Ogueta C I, Reyes V C, et al. Congenital erythropoietic porphyria: case report and management recommendations[J]. Arch Argent Pediatr, 2018, 116(2): e300-e302. DOI: 10.5546/aap.2018.e300 .
[18]
Di Pierro E, Russo R, Karakas Z, et al. Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis[J]. Eur J Haematol, 2015, 94(6): 491-497. DOI: 10.1111/ejh.12452 .
[19]
Thien Kim DH, Kawazoe A, Bang PD, et al. Congenital erythropoietic porphyria: mutation of the uroporphyrinogen III cosynthase gene in a Vietnamese patient[J]. Case Rep Dermatol, 2013, 5(1): 105-110. PMCID: PMC3635963. DOI: 10.1159/000350679 .
[20]
Baran M, Eliaçık K, Kurt I, et al. Bullous skin lesions in a jaundiced infant after phototherapy: a case of congenital erythropoietic porphyria[J]. Turk J Pediatr, 2013, 55(2): 218-221.
[21]
Hogeling M, Nakano T, Dvorak CC, et al. Severe neonatal congenital erythropoietic porphyria[J]. Pediatr Dermatol, 2011, 28(4): 416-420. DOI: 10.1111/j.1525-1470.2010.01376.x .
[22]
Pandey M, Mukherjee SB, Patra B, et al. Report of a novel Indian case of congenital erythropoietic porphyria and overview of therapeutic options[J]. J Pediatr Hematol Oncol, 2013, 35(4): e167-e170. DOI: 10.1097/MPH.0b013e3182707218 .
[23]
Martinez Peinado C, Díaz de Heredia C, To-Figueras J, et al. Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation[J]. Pediatr Dermatol, 2013, 30(4): 484-489. DOI: 10.1111/pde.12117 .
[24]
Moghbeli M, Maleknejad M, Arabi A, et al. Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria[J]. Mol Biol Rep, 2012, 39(6): 6731-6735. DOI: 10.1007/s11033-012-1497-z .
[25]
Ciftci V, Kılavuz S, Bulut FD, et al. Congenital erythropoietic porphyria with erythrodontia: a case report[J]. Int J Paediatr Dent, 2019, 29(4): 542-548. DOI: 10.1111/ipd.12473 .
[26]
Egan DN, Yang Z, Phillips J, et al. Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria[J]. Blood, 2015, 126(2): 257-261. PMCID: PMC4497965. DOI: 10.1182/blood-2014-07-584664 .
[27]
Erwin AL, Desnick RJ. Congenital erythropoietic porphyria: recent advances[J]. Mol Genet Metab, 2019, 128(3): 288-297. PMCID: PMC6597325. DOI: 10.1016/j.ymgme.2018.12.008 .
[28]
Katugampola RP, Anstey AV, Finlay AY, et al. A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases[J]. Br J Dermatol, 2012, 167(4): 888-900. DOI: 10.1111/j.1365-2133.2012.11154.x .
[29]
Blouin JM, Bernardo-Seisdedos G, Sasso E, et al. Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition[J]. Hum Mol Genet, 2017, 26(8): 1565-1576. DOI: 10.1093/hmg/ddx067 .
[30]
Blouin JM, Duchartre Y, Costet P, et al. Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria[J]. Proc Natl Acad Sci U S A, 2013, 110(45): 18238-18243. PMCID: PMC3831495 . DOI: 10.1073/pnas.1314177110 .
[31]
Guarini L, Piomelli S, Poh-Fitzpatrick MB. Hydroxyurea in congenital erythropoietic porphyria[J]. N Engl J Med, 1994, 330(15): 1091-1092. DOI: 10.1056/NEJM199404143301519 .
[32]
Peterlin P, Bonnelye J, Garnier A, et al. Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation in an adult: a case report[J]. Skin Health Dis, 2024, 4(2): e342. PMCID: PMC10988712. DOI: 10.1002/ski2.342 .
[33]
Besnard C, Schmitt C, Galmiche-Rolland L, et al. Bone marrow transplantation in congenital erythropoietic porphyria: sustained efficacy but unexpected liver dysfunction[J]. Biol Blood Marrow Transplant, 2020, 26(4): 704-711. DOI: 10.1016/j.bbmt.2019.12.005 .
[34]
Thomas C, Ged C, Nordmann Y, et al. Correction of congenital erythropoietic porphyria by bone marrow transplantation[J]. J Pediatr, 1996, 129(3): 453-456. DOI: 10.1016/s0022-3476(96)70082-3 .
[35]
Karakurt N, Tavil B, Azik F, et al. Successful hematopoietic stem cell transplantation in a child with congenital erythropoietic porphyria due to a mutation in GATA-1 [J]. Pediatr Transplant, 2015, 19(7): 803-805. DOI: 10.1111/petr.12571 .
[36]
Dupuis-Girod S, Akkari V, Ged C, et al. Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Günther disease)[J]. Eur J Pediatr, 2005, 164(2): 104-107. DOI: 10.1007/s00431-004-1575-x .
[37]
ben Bdira F, González E, Pluta P, et al. Tuning intracellular homeostasis of human uroporphyrinogen III synthase by enzyme engineering at a single hotspot of congenital erythropoietic porphyria[J]. Hum Mol Genet, 2014, 23(21): 5805-5813. DOI: 10.1093/hmg/ddu298 .
[38]
Prat F, Toutain J, Boutin J, et al. Mutation-specific guide RNA for compound heterozygous porphyria on-target scarless correction by CRISPR/Cas9 in stem cells[J]. Stem Cell Reports, 2020, 15(3): 677-693. PMCID: PMC7486222. DOI: 10.1016/j.stemcr.2020.07.015 .

脚注

所有作者均声明无利益冲突。


编委: 张辉

版权

版权所有 © 2023中国当代儿科杂志
PDF(734 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/